EUCOMED announces reshuffle as it awaits new head
This article was originally published in Clinica
Europe's largest medical device industry association, EUCOMED, is preparing for a new era as it undergoes a general reshuffle of responsibilities. In anticipation of the imminent announcement of a new director general, the present incumbent, Michael Baker, who has held the position for six years has gone part-time. Zeger Vercouteren, who joined the association in 1994 has been promoted to the position of deputy director general.
You may also be interested in...
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.
FDA has little in the way of good information it can list on its CBD policy agenda so far, says Principal Deputy Commissioner Amy Abernethy. At recent regulatory conference, she said, "Like it or not, there is a massive human experiment going on right now. There’s CBD in most different product categories and people of many different backgrounds with potential vulnerabilities taking CBD."
FDA is worried about drug names that could appear to overstate efficacy and impact consumer and healthcare provider perceptions of the product.